Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette–Guérin immunotherapy on the outcome

By Zieger Karsten   Jensen Klaus Møller-Ernst  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 6, 2011-12 ,pp. : 411-418

Informa Healthcare

Access to resources Recommend Favorite

Intravesical bacille Calmette–Guérin-induced multiorgan failure after treatment for transitional cell carcinoma

By Kiely Bridget   McLaughlin Anne Marie   Lynch Thomas H.   Keane Joseph  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 4, 2011-09 ,pp. : 278-280

Informa Healthcare

Access to resources Recommend Favorite

Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guerin

By Sarosdy M.F.   Manyak M.J.   Sagalowsky A.I.   Belldegrun A.   Benson M.C.   Bihrle W.   Carroll P.R.   Ellis W.J.   Hudson M.A.   Sharkey F.E.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 226-231

Elsevier

Access to resources Recommend Favorite

Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter

By Irie A.   Iwamura M.   Kadowaki K.   Ohkawa A.   Uchida T.   Baba S.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience

By Pansadoro V.   Emiliozzi P.   de Paula F.   Scarpone P.   Pansadoro A.   Sternberg C.N.  

Urology, Vol. 59, Iss. 2, 2002-02 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite